197 related articles for article (PubMed ID: 18356119)
1. Successful treatment of cepacia syndrome with combination nebulised and intravenous antibiotic therapy.
Weidmann A; Webb AK; Dodd ME; Jones AM
J Cyst Fibros; 2008 Sep; 7(5):409-11. PubMed ID: 18356119
[TBL] [Abstract][Full Text] [Related]
2. Can Burkholderia cepacia complex be eradicated with nebulised amiloride and TOBI?
Ball R; Brownlee KG; Duff AJ; Denton M; Conway SP; Lee TW
J Cyst Fibros; 2010 Jan; 9(1):73-4. PubMed ID: 19932062
[No Abstract] [Full Text] [Related]
3. Successful treatment of cepacia syndrome with a combination of intravenous cyclosporin, antibiotics and oral corticosteroids.
Gilchrist FJ; Webb AK; Bright-Thomas RJ; Jones AM
J Cyst Fibros; 2012 Sep; 11(5):458-60. PubMed ID: 22551926
[TBL] [Abstract][Full Text] [Related]
4. Combination aerosol therapy to treat Burkholderia cepacia complex.
Middleton PG; Kidd TJ; Williams B
Eur Respir J; 2005 Aug; 26(2):305-8. PubMed ID: 16055880
[TBL] [Abstract][Full Text] [Related]
5. Temocillin in the treatment of Burkholderia cepacia infection in cystic fibrosis.
Lekkas A; Gyi KM; Hodson ME
J Cyst Fibros; 2006 May; 5(2):121-4. PubMed ID: 16650744
[TBL] [Abstract][Full Text] [Related]
6. Empiric treatment of multidrug-resistant Burkholderia cepacia lung exacerbation in a patient with cystic fibrosis: application of pharmacodynamic concepts to meropenem therapy.
Kuti JL; Moss KM; Nicolau DP; Knauft RF
Pharmacotherapy; 2004 Nov; 24(11):1641-5. PubMed ID: 15537567
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of cepacia syndrome.
Grimwood K; Kidd TJ; Tweed M
J Cyst Fibros; 2009 Jul; 8(4):291-3. PubMed ID: 19411195
[No Abstract] [Full Text] [Related]
8. Sputum antibiotic concentrations: implications for treatment of cystic fibrosis lung infection.
Moriarty TF; McElnay JC; Elborn JS; Tunney MM
Pediatr Pulmonol; 2007 Nov; 42(11):1008-17. PubMed ID: 17902147
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
Latzin P; Fehling M; Bauernfeind A; Reinhardt D; Kappler M; Griese M
J Cyst Fibros; 2008 Mar; 7(2):142-6. PubMed ID: 17766190
[TBL] [Abstract][Full Text] [Related]
10. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.
Aaron SD; Ferris W; Henry DA; Speert DP; Macdonald NE
Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1206-12. PubMed ID: 10764313
[TBL] [Abstract][Full Text] [Related]
11. Successful meropenem desensitization in a patient with cystic fibrosis.
Wilson DL; Owens RC; Zuckerman JB
Ann Pharmacother; 2003 Oct; 37(10):1424-8. PubMed ID: 14519038
[TBL] [Abstract][Full Text] [Related]
12. Implementation of European standards of care for cystic fibrosis--control and treatment of infection.
Elborn JS; Hodson M; Bertram C
J Cyst Fibros; 2009 May; 8(3):211-7. PubMed ID: 19372063
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis.
Blumer JL; Saiman L; Konstan MW; Melnick D
Chest; 2005 Oct; 128(4):2336-46. PubMed ID: 16236892
[TBL] [Abstract][Full Text] [Related]
14. Mediastinal abscess after lung transplantation secondary to Burkholderia gladioli infection.
Church AC; Sivasothy P; Parmer J; Foweraker J
J Heart Lung Transplant; 2009 May; 28(5):511-4. PubMed ID: 19416783
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Zhou J; Chen Y; Tabibi S; Alba L; Garber E; Saiman L
Antimicrob Agents Chemother; 2007 Mar; 51(3):1085-8. PubMed ID: 17158942
[TBL] [Abstract][Full Text] [Related]
16. Two case reports of the successful eradication of new isolates of Burkholderia cepacia complex in children with cystic fibrosis.
Kitt H; Lenney W; Gilchrist FJ
BMC Pharmacol Toxicol; 2016 Mar; 17():14. PubMed ID: 27018049
[TBL] [Abstract][Full Text] [Related]
17. Survival of lung transplant patients with cystic fibrosis harboring panresistant bacteria other than Burkholderia cepacia, compared with patients harboring sensitive bacteria.
Hadjiliadis D; Steele MP; Chaparro C; Singer LG; Waddell TK; Hutcheon MA; Davis RD; Tullis DE; Palmer SM; Keshavjee S
J Heart Lung Transplant; 2007 Aug; 26(8):834-8. PubMed ID: 17692788
[TBL] [Abstract][Full Text] [Related]
18. A randomized double-blinded placebo-controlled crossover trial of nebulized taurolidine in adult cystic fibrosis patients infected with Burkholderia cepacia.
Ledson MJ; Gallagher MJ; Robinson M; Cowperthwaite C; Williets T; Hart CA; Walshaw MJ
J Aerosol Med; 2002; 15(1):51-7. PubMed ID: 12006145
[TBL] [Abstract][Full Text] [Related]
19. Burkholderia cepacia complex infection in adult patients with cystic fibrosis--is early eradication possible?
Etherington C; Peckham DG; Conway SP; Denton M
J Cyst Fibros; 2003 Dec; 2(4):220-1. PubMed ID: 15463878
[No Abstract] [Full Text] [Related]
20. [Cystic fibrosis and Burkholderia (formerly Pseudomonas) cepacia: an increasing clinical and psychosocial problem].
Horrevorts AM; Heijerman HG; Möller AV; Dankert-Roelse JE; Mouton JW; van der Laag J; Dankert J
Ned Tijdschr Geneeskd; 1995 Nov; 139(46):2343-6. PubMed ID: 7501071
[No Abstract] [Full Text] [Related]
[Next] [New Search]
